Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma

European Journal of Cancer(2020)10.1016/j.ejca.2019.12.006Source: DataRank Database

Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma is a research paper published in European Journal of Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 3.06)OA: bronzeTopics (42)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Fushen Sha ORCID,Anna Alperovich ORCID,Ai Ni ORCID,Katy Smith,Zhitao Ying ORCID

Live enrichment

PubMed:31927165 PMC:PMC7331469 OpenAlex:https://openalex.org/W2999786719

NCI NIH HHS

Grant: P30 CA008748

National Cancer Institute

FWCI

3.06

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: cc-by

journalhttp://www.ejcancer.com/article/S0959804919308585/pdf

publisherhttp://www.ejcancer.com/article/S0959804919308585/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0959804919308585?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0959804919308585?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ejca.2019.12.006

Fields of Study

Lymphoma Diagnosis and TreatmentCutaneous lymphoproliferative disorders researchCNS Lymphoma Diagnosis and Treatment

MeSH Terms

RituximabAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDoxorubicinFemaleHumansLymphoma, FollicularMaleMiddle AgedNeoplasm StagingPrednisonePrognosisRetrospective StudiesTomography, X-Ray ComputedVincristineDisease ProgressionPositron-Emission TomographyKaplan-Meier EstimateYoung Adult

Keywords

MedicineRituximabPositron emission tomographyFollicular lymphomaRetrospective cohort studyCohortVincristineRadiologyStage (stratigraphy)LymphomaInternal medicineCyclophosphamideChemotherapyPETR-chopEarly ProgressionPfs24

Sustainable Development Goals

SDG 0: Good health and well-being